摘要
目的探讨晚期肺癌患者合并严重肺感染的临床特点及治疗。方法对2001-2006年间我科收治100例肺癌晚期合并严重肺感染患者病因、病原菌特征、临床表现及治疗行回顾性分析。结果100例患者中82例有不同疗程放化疗,45例因喘息、放化疗辅助用药等有激素应用史,45例患者合并慢支、肺气肿、糖尿病等基础疾病,38例患者继发真菌感染,18例患者继发结核感染,28例患者行气管切开痰液引流,联合应用抗生素患者64例,用抗生素时间大于1月患者41例,大多数患者直接死因为呼吸衰竭。结论正确选择、合理应用抗生素;有效的呼吸道引流,重视患者原发病灶及基础疾病控制,提高机体免疫力等综合治疗,才能有效提高晚期肺癌合并严重肺感染患者生存率。
Objective To explore the clinical features and treatment of 100 cases in the advanced stage of lung cancer with sever pulmonary infection. Methods It was retrospectively analyzed to causes, pathogens, clinical expressions and therapy of 100 hospitalized patients in the advanced stage of lung cancer with sever pulmonary infection from 2001 to 2006. Results There were 82 cases which received antimicrobial or radiotherapy in different doses, 45 cases ever used chemotherapy, 45 cases with primary disease of chronic bronchitis and emphysema and diabetes, 38 cases with secondary infections of fungi, tracheotomy performed in 28 cases for sputum-expelling, 64 cases used varied antibiotics, 41 cases used antibiotics for a month or more. Respiratory was the most cause leading to the patients＇ death. Conclusion That combined with the therapy of rational choice and application to antibiotics, effective respiratory tract drainage, the control of the primary cancer, the coexisting illness and enhancing organism immunity can effectively improve survival rate of the advanced stage of lung cancer with sever pulmonary infection.
出处
《中国现代医药杂志》
2006年第5期19-21,共3页
Modern Medicine Journal of China
关键词
肺癌
肺感染
治疗
Lung cancer Pulmonary infection Treatment
